Neurological ischemic attack and interleukin-2 therapy.
Donnet
A
A
Tubiana
N
N
Chinot
O
O
Juin
P
P
D000368:Aged; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D002546:Ischemic Attack, Transient / Q000139:chemically induced*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D007376:Interleukin-2; D011994:Recombinant Proteins; D014747:Vinblastine